Skip to main content

Table 2 Antibiotic resistance patterns of isolates (number showing resistance / isolates with antibiotic sensitivity data available)

From: Ambulatory consolidation chemotherapy for acute myeloid leukemia with antibacterial prophylaxis is associated with frequent bacteremia and the emergence of fluoroquinolone resistant E. Coli

 

Consolidation 1

Consolidation 2

 

(% of isolates)

(% of isolates)

CNST

20 (37.7%)

23 (32.4%)

Vancomycin resistant

1 / 15

0 / 21

Cloxacillin resistant

14 / 17

21 / 22

Streptococcus species

9 (17%)

17 (23.9%)

Penicillin resistant

1 / 7

0 / 11

Vancomycin resistant

0 / 3

0 / 6

Gram Negatives

11 (20.7%)

20 (28.1%)

Ciprofloxacin resistant

2 / 10

8 / 15

P/T* resistant

1 / 10

0 / 14

Ampicillin resistant

9 / 9

13 / 15

Tobramycin resistant

1 / 8

3 / 10

Klebsiella species

2 (3.8%)

5 (7.0%)

Ciprofloxacin resistant

0/2

0 / 4

P/T* resistant

0/2

0 / 4

Ampicillin resistant

2/2

4 / 4

Tobramycin resistant

0/2

0 / 3

Escherichia coli

1 (1.9%)

10 (14.1%)

Ciprofloxacin resistant

1/1

8 / 8

P/T* resistant

0 / 1

0 / 8

Ampicillin resistant

1 / 1

7 / 8

Tobramycin resistant

1/1

3 / 5

Pseudomonas species

4 (7.6%)

-

Ciprofloxacin resistant

1 / 4

-

P/T* resistant

1/1

-

Ampicillin resistant

3/3

-

Tobramycin resistant

0 / 4

-

  1. *P/T = Piperacillin/tazobactam.